IMMUNE PHARMACEUTICALS INC License Agreements
7 Contracts & Agreements
- LICENSE AND COMMERCIALIZATION AGREEMENT (Filed With SEC on July 12, 2017)
- AMENDMENT NO. 1 TO LICENSE OPTION AGREEMENT (Filed With SEC on July 19, 2016)
- License Option Agreement (Filed With SEC on May 16, 2016)
- RESEARCH AND LICENSE AGREEMENT Made in Jerusalem January 1, 2016 (the “EffectiveDate”), by and between: (Filed With SEC on January 7, 2016)
- RESEARCH AND LICENSE AGREEMENT (Filed With SEC on June 29, 2015)
- AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on September 17, 2008)
- EX-10.1: LICENSE AGREEMENT (Filed With SEC on January 25, 2007)
